The study involved 70 patients with MS, and the results showed that probiotic supplementation led to a significant increase in brain-derived neurotrophic factor (BDNF) levels and a substantial decrease in the inflammatory factor IL-6 levels17. The gene discussed is BDNF; the disease is myeloid sarcoma.